DNA Damage and Repair Biomarkers of Immunotherapy Response

DNA-damaging agents are widely used in clinical oncology and exploit deficiencies in tumor DNA repair. Given the expanding role of immune checkpoint blockade as a therapeutic strategy, the interaction of tumor DNA damage with the immune system has recently come into focus, and it is now clear that t...

Celý popis

Podrobná bibliografie

Vydáno v:	Cancer discovery Ročník 7; číslo 7; s. 675
Hlavní autoři:	Mouw, Kent W, Goldberg, Michael S, Konstantinopoulos, Panagiotis A, D'Andrea, Alan D
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.07.2017
Témata:	Antineoplastic Agents - immunology Antineoplastic Agents - therapeutic use Biomarkers, Tumor - genetics Biomarkers, Tumor - immunology DNA Damage - drug effects DNA Damage - immunology DNA Repair - drug effects DNA Repair - immunology Genomic Instability - drug effects Genomic Instability - immunology Humans Immunotherapy - adverse effects Neoplasms - genetics Neoplasms - immunology Neoplasms - therapy
ISSN:	2159-8290, 2159-8290
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!